AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $136.3M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| TAM | Jims Yields High Grade Intercepts | PRICE SENSITIVE | 04/02/25 | |
| TAM | Half Yearly Report and Accounts | 16/03/18 | ||
| TAM | Quarterly Report and Appendix 5B | PRICE SENSITIVE | 30/01/18 | |
| TAM Jims Yields High Grade Intercepts | |||
| 04/02/25 | PRICE SENSITIVE | ||
| TAM Half Yearly Report and Accounts | |||
| 16/03/18 | |||
| TAM Quarterly Report and Appendix 5B | |||
| 30/01/18 | PRICE SENSITIVE | ||
